The Capital Network

Last month @4DMedicalXV announced a significant milestone with our lung technology,  CT:VQ™ being approved by the Therapeutic Goods Administration (TGA). @SevenNetwork National Health Editor @jenbechwati reported on the launch, featuring insights from Professor Lucy Morgan. After more than two decades of research and development, it's incredibly rewarding to see Australian innovation recognised for its potential to transform respiratory care, having already been adopted by leading hospitals internationally. Seven Network highlighted: 1. 4DMedical's Australian innovation recognised nationally Raising awareness of how advanced imaging can support clinicians and improve patient care across Australia. 2. Expert clinical validation Professor Lucy Morgan describing our technology as a "game changer" for patients with complex lung conditions. 3. Bringing world-leading technology home Already used by leading institutions across the United States, CT:VQ™ is now approved for use in Australia. Because our software solution works with existing CT scanners, it has the potential to be deployed widely and improve access to advanced respiratory imaging for patients around the world. Thank you to Jennifer Bechwati and the 7News team for sharing our story, and to Professor Lucy Morgan for helping explain the clinical significance of our technology. 7News report: 7news.com.au/video/news/aust… 7News video: youtube.com/watch?v=ZXWsKvuF… TGA approval ASX announcement: cdn-api.markitdigital.com/ap…